| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817984 | Clinical Biochemistry | 2013 | 7 Pages |
Abstract
NT-proANP and NT-proBNP are powerful markers of 30-day-mortality in patients with acute heart failure of ischemic and non-ischemic origins. With respect to the prediction of 30-day-mortality, NT-proBNP plasma levels at 12Â h after admission are comparable with NT-proANP plasma levels on admission. These data underline the fact that with regard to etiology-dependent hemodynamic changes and plasma half-time, the determination of peak plasma levels is of highest importance for the estimation of the impact of natriuretic peptides on the prognosis of patients with decompensated heart failure.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Claus Luers, Anke Sutcliffe, Lutz Binder, Sebastian Irle, Burkert Pieske,